Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ZBIOZBIO
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ZENAS BIOPHARMA INC

Yes. Bank of America holds 1,231,159 shares of ZBIO (Zenas Biopharma), worth $31.2M, as of its Q2 2026 13F filing. It increased the position from 388,347 shares in Q1 2026. Bank of America has held ZBIO since Q4 2024, across 7 quarterly 13F filings.

Current Value

$31.2M

Current Shares

1.2M

Total Value Change

+$31.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+217.0%
$31.2M0.0%$25.38
47
2026-Q1
Increased
388,347
+723.5%
$7.6M0.0%$25.18
44
2025-Q4
Increased
47,160
+218.4%
$1.7M0.0%$36.58
41
2025-Q3
Increased
14,809
+5.8%
$328,7600.0%$20.57
17
2025-Q2
Increased
13,991
+32.3%
$135,5720.0%$9.58
19
2025-Q1
Decreased
10,579
-51.0%
$83,5740.0%$8.17
0
2024-Q4
New
21,575
-
$176,6990.0%$8.99
35

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used